Innovators and Investors: The Journey from Entry to Exit

Breakfast Buffet, Hot Lunch, and Free Parking are included.

The Life Sciences Collaborative is proud to invite you to our 7th annual conference at USciences in Philadelphia.

Along with a breakfast buffet, lunch, networking with peers/influencers, and free parking, our program will include:

Philadelphia is consistently ranked in the top 10 life sciences clusters in the country, due to our proximity to Big Pharma, excellent research institutions, and robust talent pool. Venture capital funding of Philly-based life sciences companies, while still trailing Boston, San Francisco, San Diego, and others, has grown significantly in the last several years. With our maturing eco-system, now is a great time to start or grow a life sciences company in the region.

However, we realize that emerging life science companies in our region face a lot of challenges. These challenges include navigating the balance between building a business and optimizing scientific progress, sourcing and working with investors, and entering into commercialization.

Come join the Life Sciences Collaborative for our 7th annual conference to hear from both innovators and investors on their journeys to building sustainable and profitable life sciences businesses.

During the program you will hear from experienced founders who will share stories from the trenches on how they started and seeded their business, what they experienced during growth and how they took their company public or exited. We will also hear how investors recognize and decide on when and what to invest in, and who they want to engage with as partners.

The Life Sciences Collaborative would like for you to engage and learn from this year’s event about the challenges and successes of others, while networking with fellow life science colleagues. Whether your life science cycle is set, or you need to redefine how you prepare your business for the future, this event’s objective is for you to learn, share and develop relationships with others within this ever-evolving life sciences landscape.

We look forward to you joining this esteemed group of speakers in what proves to be a great event for learning, engaging and networking.

Individual Presenters

Chris Cashman
Chairman, MBF Therapeutics

Louis P. Kassa III, MBA
Executive VP & COO, Pennsylvania Biotechnology Center of Bucks Co, Baruch S. Blumberg Institute & Hepititis B Foundation

Adam Lohr
Partner & Senior Analyst, RSM US LLP

J. David Owens
Biopharmaceutical Executive, Entrpreneur, Angel Investor, Board Member

Licensing Panel

Ihor Terleckyj (Moderator)
CEO, CuRAGE Therapeutics

Ahmet Hamdi Cavusoglu, Ph.D.
Director, Academnic Venture Exchange

Michael Poisel
Executive Director, PCI Ventures

Steve Nappi
Associate VP of Technology Commercialization & Business Development, Temple University

Paul Jeffrey
Partner, BusStim, Virtual Biotech Accelerator

Pricing Panel

Amy Williams (Moderator)
President and Managing Partner, SageWorks Rx LLC

Shekhar Yerramilli
Founder & CEO, The Guiding Start

Joshua Parks
Founder, Chiral Logic

Dr. Maria Lopes
Former Chief Medical Officer, MagellanRx

Maximilian Vargas, PhD, MBA
Senior Director, US Access Strategy and Account Management, Certara

Funding Panel

Dennis Steadman (Moderator)
President, Steadman Consulting, LLC & Steadman Capital, LLC

Anthony P. Green, PhD
Vice President, Science and Technology, Ben Franklin Technology Partners of Southern Pennsylvania

Daron Evans
Managing Director, PoC Capital

Susan Dillon, PhD
Co-Founder, President and CEO, Aro Biotherapeutics Company

Andrew Olsen
Principal, Boathouse Capital

Exits Panel

Ryan Udell (Moderator)
Partner, Corporate and Securities Group, White and Williams

Adele Oliva
Founding Partner, 1315 Capital

John Gregg
CEO, BalinBac Therapeutics

Matt Steere
Managing Director, Canaccord Financial

Robert P. Ryan, PhD, D.A.B.T.
President & CEO, Innova Therapeutics, Inc.